fainting on glp 1 Vertigo from GLP-1 Injections GLP-1 drugs tied to blood

J Card Fail (2006) 12(9):6949

Barnett C, Costill DL, Vukovich MD, Cole KJ, Goodpaster BH, Trappe SW, Fink WJ

This is a reasonable position, and it is one of the arguments the July panel will need to weigh carefully against the absence of rigorous human trial data

Patients seeking GLP-1 therapy should rely on FDA-approved medications with established efficacy profiles, including landmark trials like STEP (semaglutide) demonstrating approximately 15% body weight reduction and SCALE (liraglutide) showing 5-8% weight reduction, along with improved glycemic control in patients with diabetes

We do not prescribe the same protocol to every patient